Results 221 to 230 of about 117,638 (289)
The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus
, 2014 Aura R. Garrison, Barbara Giomarelli, Calli M. Lear-Rooney, Carrie J. Saucedo, Srikanth Yellayi, Lauren R. H. Krumpe, Maura Rose, Jason Paragas, Mike Bray, Gene G. Olinger, James B. McMahon, John W. Huggins, Barry R. O’Keefe +12 moreopenalex +2 more sourcesSeven Strategies Implemented in Response to the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo: Lessons Learned over a Three-Month Period. [PDF]
VirusesMwamba DK, Angendu KB, Diouf W, Mikobi MC, Leonard O, Kalala D, Ntumba N, Kakule D, Kayembe DK, Sana E, Kabasele B, Katya J, Montoyo A, Serra B, Bulambo H, Otshudiema J, Kapanga S, Balayulu O, Muya J, Kamangu E, Kitenge R, Tshapenda G, Kasita C, Keita M, Kabasubabo FK, Kombe J, Mossoko M, Ngandu CB, Manianga C, Moullec G, Zarowsky C, Akilimali PZ. +31 moreeuropepmc +1 more sourcePhylogenetic analysis of initial Ebola virus genomes from the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo, September 2025
Wawina-Bokalanga T, Amuri A, Luakanda G, Makangara-Cigolo J, Kinganda-Lusamaki E, Ngandu C, Bula-Loso S, Mossoko M, Tshulo L, Akil-Bandali P, Kitenge R, Brosius I, Lokilo E, Kimbonza S, Paku-Tshambu P, Ngonda-Tshibinda A, Kuispond-Swar N, Ayouba A, Nsio J, Mbantshi-Beya J, Cikaya-Kankolongo F, Ntumba-Tshitenge O, Keita M, Mukadi P, Mukadi-Bamuleka D, Tshiani-Mbaya O, Mulangu S, Quick J, Loman N, O’Toole Á, Mwamba D, Delaporte E, Hensley L, Rimoin A, Wilkinson S, Peeters M, Ahuka-Mundeke S, Liesenborghs L, Kindrachuk J, Low N, Carroll M, Maes P, Vercauteren K, Muyembe-Tamfum J, Kuppalli K, Rambaut A, Wawina-Bokalanga T, Mbala P. +47 moreeuropepmc +1 more sourceUnderstanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation. [PDF]
BMJ OpenHartley CD, Linderman S, Fashina T, Ward L, Drews-Botsch C, Pratt C, Kuthyar S, Fernandes AF, Huang Y, Choo C, Nguyen N, Carag J, Morgan J, Kraft CS, Hewlett A, Brett-Major D, Schieffelin JS, Garry RF, Grant D, Justin GA, Conrady CD, Smith JR, Hayek BR, Balendra S, Acharya N, Doan T, Legand A, Formenty P, Zeng X, Conteh I, Vandy MJ, Harrison-Williams L, Mustapha J, Koroma Z, Wiley MR, Crozier I, Mwanza JC, Shantha JG, Ahmed R, Yeh S, SMILE and EVICT-VR Investigator Study Groups. +40 moreeuropepmc +1 more sourceEbola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signaling. [PDF]
Proc Natl Acad Sci U S AUwase G, Luthra P, Vogel OA, Batra J, La Rosa BA, Sheehan KCF, Khatavkar O, Payton JE, Davey RA, Krogan NJ, Basler CF, Leung DW, Amarasinghe GK. +12 moreeuropepmc +1 more sourceAuthor Response: Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
Lin Zhu, Jing Jin, Tingting Wang, Yong Hu, Hainan Liu, Ting Gao, Qincai Dong, Yanwen Jin, Ping Li, Zijing Liu, Yi Huang, Xuan Liu, Cheng Cao +12 moreopenalex +1 more sourceMonotherapy with antibody 1C3 partially protects Ebola virus-exposed macaques. [PDF]
J VirolWorwa G, Davis CW, Klim SE, Turcinovic J, Agans KN, Borisevich V, Geisbert JB, Cross RW, Crane A, Holbrook MR, Sanchez-Lockhart M, Kugelman JR, Patino Galindo JA, Geisbert TW, Ahmed R, Kuhn JH, Saphire EO, Palacios G, Crozier I. +18 moreeuropepmc +1 more source
